Cyclophosphamide Capsule
Product Images NDC 46708-618

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 46708-618). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 Capsules (Cyclophosphamide 25 mg)

Each capsule contains 25g of Cyclophosphamide USP, which is a cytotoxic agent that is used for the treatment of certain types of cancer. The package insert should be consulted for the correct dosage and prescribing information. The capsules should be swallowed whole and not opened, chewed, or crushed. The storage temperature range is between 20 to 25°C (68 to 77°F), with excursions permitted from 15 to 30°C (59 to 86°F). The product is manufactured by Alembic Pharmaceuticals Limited located in India. The package contains 100 capsules. No further description or indication of its indications or uses available.*

FDA Label Image

100 Capsules (Cyclophosphamide 50 mg)

This is a description for Cyclophosphamide Capsules containing 50g of Crolophards U5. The usual dosage is to swallow the capsules whole and not to open them. The recommended storage temperature is between 15-30°C. These capsules are manufactured by Alambic Pharmaceuticals Limited in India and are a cytotoxic agent. The NDC number is 46708-619-31 and the package contains 100 capsules. The label includes other important information such as dosage instructions and a warning not to crush the capsules.*

FDA Label Image

Cyclophosphamide-str.jpg (Cyclophosphamide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.